Botulinum Toxin for Treatment of Seborrhic Dermatitis in Parkinsonian Patients

NCT00767546 · clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
40
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Rabin Medical Center